PCNA and ovarian cancer: Bruning et al. reported that nelfinavir reduced the level of cell cycle proteins cyclin A, cyclin B, cyclin D3, cyclin-dependent kinase (CDK) 1, CDK2, and proliferating cell nuclear antigen (PCNA) in ovarian cancer cell lines in a time-dependent manner [21].